Piotr Jachimczak Person-Info 

( Ich bin Piotr Jachimczak)

News

(1 - 4 von 5
)

Antisense Pharma Leads Session on TGF-ß at GEN Drug Discovery Summit...

www.b3cnewswire.com
Then Dr. Piotr Jachimczak, physician and senior scientific advisor at Antisense Pharma, informed about therapies targeting TGF-β. In his doctoral thesis he had already demonstrated for the first time that the targeted inhibition of mRNA encoding TGF-β2 by antisense oligodeoxynucleotides may ...

Study shows trabedersen as beneficial therapy of high-grade gliomas -...

ecancer.org
Results of a Phase IIb study, presented at the American Association for Cancer Research 101st Annual Meeting 2010, showed a clear clinical benefit from trabeder

TGF-beta2 inhibitor has clinical benefit in high-grade gliomas

www.healio.com
AACR st Annual Meeting WASHINGTON, D.C. — The use of trabedersen, a TGF-beta2 specific phosphorothioate antisense oligonucleotide, in patients...

Join: GEN Drug Discovery Theatre at BIOTECHNICA 2010

www.b3cnewswire.com
Dr. Piotr Jachimczak, physician and senior scientific advisor at Antisense Pharma, Regensburg. Therapies targeting TGF- β – an overview . PD Dr. Peter Hau, section leader
Dossier exportieren
+1